Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancer
- 31 January 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (1) , 53-58
- https://doi.org/10.1016/0959-8049(92)90384-e
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Survival with Intraperitoneal Cisplatin in Advanced Ovarian Cancer after Second-Look LaparotomyAmerican Journal of Clinical Oncology, 1992
- Schedule and dosage modification of a cyclophosphamide, hexamethylmelamine, doxorubicin, cisplatin combination chemotherapy regimen for refractory ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectivesEuropean Journal of Cancer and Clinical Oncology, 1989
- Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989
- Survival after second-look laparotomy in advanced ovarian epithelial cancer: Study of 86 patientsEuropean Journal of Cancer and Clinical Oncology, 1989
- Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.Journal of Clinical Oncology, 1986
- COMPLETE REMISSION AT LAPAROTOMY: STILL A GOLD STANDARD IN OVARIAN CANCER?The Lancet, 1986
- Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity.Journal of Clinical Oncology, 1985
- Adriamycin and cis-platinum in advanced ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- Factors influencing survival in carcinoma of the ovary. Study from a well-defined swedish populationCancer, 1985